Global Monogenetic Disorders Testing Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Monogenetic Disorders Testing Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Carrier Testing
1.2.3 Diagnostic Testing
1.2.4 New-Born Screening
1.2.5 Predictive & Pre-Symptomatic Testing
1.2.6 Prenatal Testing
1.2.7 Others
1.3 Market by Application
1.3.1 Global Monogenetic Disorders Testing Market Growth Rate by Application: 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Specialized Clinics
1.3.4 Ambulatory Surgical Centers
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Monogenetic Disorders Testing Market Size (2017-2028)
2.2 Monogenetic Disorders Testing Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.3 Global Monogenetic Disorders Testing Market Size by Region (2017-2022)
2.4 Global Monogenetic Disorders Testing Market Size Forecast by Region (2023-2028)
2.5 Global Top Monogenetic Disorders Testing Countries Ranking by Market Size
3 Monogenetic Disorders Testing Competitive by Company
3.1 Global Monogenetic Disorders Testing Revenue by Players
3.1.1 Global Monogenetic Disorders Testing Revenue by Players (2017-2022)
3.1.2 Global Monogenetic Disorders Testing Market Share by Players (2017-2022)
3.2 Global Monogenetic Disorders Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Monogenetic Disorders Testing Revenue
3.4 Global Monogenetic Disorders Testing Market Concentration Ratio
3.4.1 Global Monogenetic Disorders Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Monogenetic Disorders Testing Revenue in 2021
3.5 Global Monogenetic Disorders Testing Key Players Head office and Area Served
3.6 Key Players Monogenetic Disorders Testing Product Solution and Service
3.7 Date of Enter into Monogenetic Disorders Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Monogenetic Disorders Testing Breakdown Data by Type
4.1 Global Monogenetic Disorders Testing Historic Revenue by Type (2017-2022)
4.2 Global Monogenetic Disorders Testing Forecasted Revenue by Type (2023-2028)
5 Global Monogenetic Disorders Testing Breakdown Data by Application
5.1 Global Monogenetic Disorders Testing Historic Market Size by Application (2017-2022)
5.2 Global Monogenetic Disorders Testing Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Monogenetic Disorders Testing Revenue by Company (2020-2022)
6.2 North America Monogenetic Disorders Testing Revenue by Type (2017-2028)
6.3 North America Monogenetic Disorders Testing Revenue by Application (2017-2028)
6.4 North America Monogenetic Disorders Testing Revenue by Country (2017-2028)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Monogenetic Disorders Testing Revenue by Company (2020-2022)
7.2 Europe Monogenetic Disorders Testing Revenue by Type (2017-2028)
7.3 Europe Monogenetic Disorders Testing Revenue by Application (2017-2028)
7.4 Europe Monogenetic Disorders Testing Revenue by Country (2017-2028)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Monogenetic Disorders Testing Revenue by Company (2020-2022)
8.2 Asia Pacific Monogenetic Disorders Testing Revenue by Type (2017-2028)
8.3 Asia Pacific Monogenetic Disorders Testing Revenue by Application (2017-2028)
8.4 Asia Pacific Monogenetic Disorders Testing Revenue by Region (2017-2028)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America Monogenetic Disorders Testing Revenue by Company (2020-2022)
9.2 Latin America Monogenetic Disorders Testing Revenue by Type (2017-2028)
9.3 Latin America Monogenetic Disorders Testing Revenue by Application (2017-2028)
9.4 Latin America Monogenetic Disorders Testing Revenue by Country (2017-2028)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Monogenetic Disorders Testing Revenue by Company (2020-2022)
10.2 Middle East and Africa Monogenetic Disorders Testing Revenue by Type (2017-2028)
10.3 Middle East and Africa Monogenetic Disorders Testing Revenue by Application (2017-2028)
10.4 Middle East and Africa Monogenetic Disorders Testing Revenue by Country (2017-2028)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11 Company Profiles
11.1 Celera Group
11.1.1 Celera Group Company Details
11.1.2 Celera Group Business Overview
11.1.3 Celera Group Monogenetic Disorders Testing Products and Services
11.1.4 Celera Group Monogenetic Disorders Testing Revenue in Monogenetic Disorders Testing Business (2017-2022)
11.1.5 Celera Group Monogenetic Disorders Testing SWOT Analysis
11.1.6 Celera Group Recent Developments
11.2 Abbott
11.2.1 Abbott Company Details
11.2.2 Abbott Business Overview
11.2.3 Abbott Monogenetic Disorders Testing Products and Services
11.2.4 Abbott Monogenetic Disorders Testing Revenue in Monogenetic Disorders Testing Business (2017-2022)
11.2.5 Abbott Monogenetic Disorders Testing SWOT Analysis
11.2.6 Abbott Recent Developments
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Details
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific Monogenetic Disorders Testing Products and Services
11.3.4 Thermo Fisher Scientific Monogenetic Disorders Testing Revenue in Monogenetic Disorders Testing Business (2017-2022)
11.3.5 Thermo Fisher Scientific Monogenetic Disorders Testing SWOT Analysis
11.3.6 Thermo Fisher Scientific Recent Developments
11.4 ELITech Group
11.4.1 ELITech Group Company Details
11.4.2 ELITech Group Business Overview
11.4.3 ELITech Group Monogenetic Disorders Testing Products and Services
11.4.4 ELITech Group Monogenetic Disorders Testing Revenue in Monogenetic Disorders Testing Business (2017-2022)
11.4.5 ELITech Group Monogenetic Disorders Testing SWOT Analysis
11.4.6 ELITech Group Recent Developments
11.5 Quest
11.5.1 Quest Company Details
11.5.2 Quest Business Overview
11.5.3 Quest Monogenetic Disorders Testing Products and Services
11.5.4 Quest Monogenetic Disorders Testing Revenue in Monogenetic Disorders Testing Business (2017-2022)
11.5.5 Quest Monogenetic Disorders Testing SWOT Analysis
11.5.6 Quest Recent Developments
11.6 AutoGenomics
11.6.1 AutoGenomics Company Details
11.6.2 AutoGenomics Business Overview
11.6.3 AutoGenomics Monogenetic Disorders Testing Products and Services
11.6.4 AutoGenomics Monogenetic Disorders Testing Revenue in Monogenetic Disorders Testing Business (2017-2022)
11.6.5 AutoGenomics Monogenetic Disorders Testing SWOT Analysis
11.6.6 AutoGenomics Recent Developments
11.7 PerkinElmer
11.7.1 PerkinElmer Company Details
11.7.2 PerkinElmer Business Overview
11.7.3 PerkinElmer Monogenetic Disorders Testing Products and Services
11.7.4 PerkinElmer Monogenetic Disorders Testing Revenue in Monogenetic Disorders Testing Business (2017-2022)
11.7.5 PerkinElmer Monogenetic Disorders Testing SWOT Analysis
11.7.6 PerkinElmer Recent Developments
11.8 Roche
11.8.1 Roche Company Details
11.8.2 Roche Business Overview
11.8.3 Roche Monogenetic Disorders Testing Products and Services
11.8.4 Roche Monogenetic Disorders Testing Revenue in Monogenetic Disorders Testing Business (2017-2022)
11.8.5 Roche Monogenetic Disorders Testing SWOT Analysis
11.8.6 Roche Recent Developments
11.9 Bio-Rad
11.9.1 Bio-Rad Company Details
11.9.2 Bio-Rad Business Overview
11.9.3 Bio-Rad Monogenetic Disorders Testing Products and Services
11.9.4 Bio-Rad Monogenetic Disorders Testing Revenue in Monogenetic Disorders Testing Business (2017-2022)
11.9.5 Bio-Rad Monogenetic Disorders Testing SWOT Analysis
11.9.6 Bio-Rad Recent Developments
11.10 Transgenomic
11.10.1 Transgenomic Company Details
11.10.2 Transgenomic Business Overview
11.10.3 Transgenomic Monogenetic Disorders Testing Products and Services
11.10.4 Transgenomic Monogenetic Disorders Testing Revenue in Monogenetic Disorders Testing Business (2017-2022)
11.10.5 Transgenomic Monogenetic Disorders Testing SWOT Analysis
11.10.6 Transgenomic Recent Developments
12 Monogenetic Disorders Testing Market Dynamics
12.1 Monogenetic Disorders Testing Market Trends
12.2 Monogenetic Disorders Testing Market Drivers
12.3 Monogenetic Disorders Testing Market Challenges
12.4 Monogenetic Disorders Testing Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of TablesTable 1. Global Monogenetic Disorders Testing Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Carrier Testing
Table 3. Key Players of Diagnostic Testing
Table 4. Key Players of New-Born Screening
Table 5. Key Players of Predictive & Pre-Symptomatic Testing
Table 6. Key Players of Prenatal Testing
Table 7. Key Players of Others
Table 8. Global Monogenetic Disorders Testing Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 9. Global Monogenetic Disorders Testing Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 10. Global Monogenetic Disorders Testing Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Monogenetic Disorders Testing Revenue Market Share by Region (2017-2022)
Table 12. Global Monogenetic Disorders Testing Revenue by Players (2017-2022) & (US$ Million)
Table 13. Global Monogenetic Disorders Testing Market Share by Players (2017-2022)
Table 14. Global Top Monogenetic Disorders Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monogenetic Disorders Testing as of 2021)
Table 15. Ranking of Global Top Monogenetic Disorders Testing Companies by Revenue (US$ Million) in 2021
Table 16. Global 5 Largest Players Market Share by Monogenetic Disorders Testing Revenue (CR5 and HHI) & (2017-2022)
Table 17. Key Players Headquarters and Area Served
Table 18. Key Players Monogenetic Disorders Testing Product Solution and Service
Table 19. Date of Key Manufacturers Enter into Monogenetic Disorders Testing Market
Table 20. Mergers & Acquisitions, Expansion Plans
Table 21. Global Monogenetic Disorders Testing Market Size by Type (2017-2022) & (US$ Million)
Table 22. Global Monogenetic Disorders Testing Revenue Market Share by Type (2017-2022)
Table 23. Global Monogenetic Disorders Testing Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 24. Global Monogenetic Disorders Testing Revenue Market Share by Type (2023-2028)
Table 25. Global Monogenetic Disorders Testing Market Size by Application (2017-2022) & (US$ Million)
Table 26. Global Monogenetic Disorders Testing Revenue Market Share by Application (2017-2022)
Table 27. Global Monogenetic Disorders Testing Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 28. Global Monogenetic Disorders Testing Revenue Market Share by Application (2023-2028)
Table 29. North America Monogenetic Disorders Testing Revenue by Company (2020-2022) & (US$ Million)
Table 30. North America Monogenetic Disorders Testing Revenue by Type (2017-2022) & (US$ Million)
Table 31. North America Monogenetic Disorders Testing Revenue by Type (2023-2028) & (US$ Million)
Table 32. North America Monogenetic Disorders Testing Revenue by Application (2017-2022) & (US$ Million)
Table 33. North America Monogenetic Disorders Testing Revenue by Application (2023-2028) & (US$ Million)
Table 34. North America Monogenetic Disorders Testing Revenue by Country (2017-2022) & (US$ Million)
Table 35. North America Monogenetic Disorders Testing Revenue by Country (2023-2028) & (US$ Million)
Table 36. Europe Monogenetic Disorders Testing Revenue by Company (2020-2022) & (US$ Million)
Table 37. Europe Monogenetic Disorders Testing Revenue by Type (2017-2022) & (US$ Million)
Table 38. Europe Monogenetic Disorders Testing Revenue by Type (2023-2028) & (US$ Million)
Table 39. Europe Monogenetic Disorders Testing Revenue by Application (2017-2022) & (US$ Million)
Table 40. Europe Monogenetic Disorders Testing Revenue by Application (2023-2028) & (US$ Million)
Table 41. Europe Monogenetic Disorders Testing Revenue by Country (2017-2022) & (US$ Million)
Table 42. Europe Monogenetic Disorders Testing Revenue by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Monogenetic Disorders Testing Revenue by Company (2020-2022) & (US$ Million)
Table 44. Asia Pacific Monogenetic Disorders Testing Revenue by Type (2017-2022) & (US$ Million)
Table 45. Asia Pacific Monogenetic Disorders Testing Revenue by Type (2023-2028) & (US$ Million)
Table 46. Asia Pacific Monogenetic Disorders Testing Revenue by Application (2017-2022) & (US$ Million)
Table 47. Asia Pacific Monogenetic Disorders Testing Revenue by Application (2023-2028) & (US$ Million)
Table 48. Asia Pacific Monogenetic Disorders Testing Revenue by Region (2017-2022) & (US$ Million)
Table 49. Asia Pacific Monogenetic Disorders Testing Revenue by Region (2023-2028) & (US$ Million)
Table 50. Latin America Monogenetic Disorders Testing Revenue by Company (2020-2022) & (US$ Million)
Table 51. Latin America Monogenetic Disorders Testing Revenue by Type (2017-2022) & (US$ Million)
Table 52. Latin America Monogenetic Disorders Testing Revenue by Type (2023-2028) & (US$ Million)
Table 53. Latin America Monogenetic Disorders Testing Revenue by Application (2017-2022) & (US$ Million)
Table 54. Latin America Monogenetic Disorders Testing Revenue by Application (2023-2028) & (US$ Million)
Table 55. Latin America Monogenetic Disorders Testing Revenue by Country (2017-2022) & (US$ Million)
Table 56. Latin America Monogenetic Disorders Testing Revenue by Country (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Monogenetic Disorders Testing Revenue by Company (2020-2022) & (US$ Million)
Table 58. Middle East and Africa Monogenetic Disorders Testing Revenue by Type (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Monogenetic Disorders Testing Revenue by Type (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Monogenetic Disorders Testing Revenue by Application (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Monogenetic Disorders Testing Revenue by Application (2023-2028) & (US$ Million)
Table 62. Middle East and Africa Monogenetic Disorders Testing Revenue by Country (2017-2022) & (US$ Million)
Table 63. Middle East and Africa Monogenetic Disorders Testing Revenue by Country (2023-2028) & (US$ Million)
Table 64. Celera Group Company Details
Table 65. Celera Group Business Overview
Table 66. Celera Group Monogenetic Disorders Testing Product and Services
Table 67. Celera Group Monogenetic Disorders Testing Revenue in Monogenetic Disorders Testing Business (2017-2022) & (US$ Million)
Table 68. Celera Group Monogenetic Disorders Testing SWOT Analysis
Table 69. Celera Group Recent Developments
Table 70. Abbott Company Details
Table 71. Abbott Business Overview
Table 72. Abbott Monogenetic Disorders Testing Product and Services
Table 73. Abbott Monogenetic Disorders Testing Revenue in Monogenetic Disorders Testing Business (2017-2022) & (US$ Million)
Table 74. Abbott Monogenetic Disorders Testing SWOT Analysis
Table 75. Abbott Recent Developments
Table 76. Thermo Fisher Scientific Company Details
Table 77. Thermo Fisher Scientific Business Overview
Table 78. Thermo Fisher Scientific Monogenetic Disorders Testing Product and Services
Table 79. Thermo Fisher Scientific Monogenetic Disorders Testing Revenue in Monogenetic Disorders Testing Business (2017-2022) & (US$ Million)
Table 80. Thermo Fisher Scientific Monogenetic Disorders Testing SWOT Analysis
Table 81. Thermo Fisher Scientific Recent Developments
Table 82. ELITech Group Company Details
Table 83. ELITech Group Business Overview
Table 84. ELITech Group Monogenetic Disorders Testing Product and Services
Table 85. ELITech Group Monogenetic Disorders Testing Revenue in Monogenetic Disorders Testing Business (2017-2022) & (US$ Million)
Table 86. ELITech Group Monogenetic Disorders Testing SWOT Analysis
Table 87. ELITech Group Recent Developments
Table 88. Quest Company Details
Table 89. Quest Business Overview
Table 90. Quest Monogenetic Disorders Testing Product and Services
Table 91. Quest Monogenetic Disorders Testing Revenue in Monogenetic Disorders Testing Business (2017-2022) & (US$ Million)
Table 92. Quest Monogenetic Disorders Testing SWOT Analysis
Table 93. Quest Recent Developments
Table 94. AutoGenomics Company Details
Table 95. AutoGenomics Business Overview
Table 96. AutoGenomics Monogenetic Disorders Testing Product and Services
Table 97. AutoGenomics Monogenetic Disorders Testing Revenue in Monogenetic Disorders Testing Business (2017-2022) & (US$ Million)
Table 98. AutoGenomics Monogenetic Disorders Testing SWOT Analysis
Table 99. AutoGenomics Recent Developments
Table 100. PerkinElmer Company Details
Table 101. PerkinElmer Business Overview
Table 102. PerkinElmer Monogenetic Disorders Testing Product and Services
Table 103. PerkinElmer Monogenetic Disorders Testing Revenue in Monogenetic Disorders Testing Business (2017-2022) & (US$ Million)
Table 104. PerkinElmer Monogenetic Disorders Testing SWOT Analysis
Table 105. PerkinElmer Recent Developments
Table 106. Roche Company Details
Table 107. Roche Business Overview
Table 108. Roche Monogenetic Disorders Testing Product and Services
Table 109. Roche Monogenetic Disorders Testing Revenue in Monogenetic Disorders Testing Business (2017-2022) & (US$ Million)
Table 110. Roche Monogenetic Disorders Testing SWOT Analysis
Table 111. Roche Recent Developments
Table 112. Bio-Rad Company Details
Table 113. Bio-Rad Business Overview
Table 114. Bio-Rad Monogenetic Disorders Testing Product and Services
Table 115. Bio-Rad Monogenetic Disorders Testing Revenue in Monogenetic Disorders Testing Business (2017-2022) & (US$ Million)
Table 116. Bio-Rad Monogenetic Disorders Testing SWOT Analysis
Table 117. Bio-Rad Recent Developments
Table 118. Transgenomic Company Details
Table 119. Transgenomic Business Overview
Table 120. Transgenomic Monogenetic Disorders Testing Product and Services
Table 121. Transgenomic Monogenetic Disorders Testing Revenue in Monogenetic Disorders Testing Business (2017-2022) & (US$ Million)
Table 122. Transgenomic Monogenetic Disorders Testing SWOT Analysis
Table 123. Transgenomic Recent Developments
Table 124. Monogenetic Disorders Testing Market Trends
Table 125. Monogenetic Disorders Testing Market Drivers
Table 126. Monogenetic Disorders Testing Market Challenges
Table 127. Monogenetic Disorders Testing Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Monogenetic Disorders Testing Sales Market Share by Type: 2021 VS 2028
Figure 2. Carrier Testing Features
Figure 3. Diagnostic Testing Features
Figure 4. New-Born Screening Features
Figure 5. Predictive & Pre-Symptomatic Testing Features
Figure 6. Prenatal Testing Features
Figure 7. Others Features
Figure 8. Global Monogenetic Disorders Testing Sales Market Share by Application: 2021 VS 2028
Figure 9. Hospitals Case Studies
Figure 10. Specialized Clinics Case Studies
Figure 11. Ambulatory Surgical Centers Case Studies
Figure 12. Monogenetic Disorders Testing Report Years Considered
Figure 13. Global Monogenetic Disorders Testing Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Monogenetic Disorders Testing Market Size 2017-2028 (US$ Million)
Figure 15. Global Monogenetic Disorders Testing Market Size Market Share by Region: 2021 VS 2028
Figure 16. Global Monogenetic Disorders Testing Revenue Market Share by Region in 2017 VS 2022
Figure 17. Global Top 10 Monogenetic Disorders Testing Countries Ranking by Market Size (US$ Million) in 2021
Figure 18. Global Monogenetic Disorders Testing Market Share by Players in 2021
Figure 19. Global Top Monogenetic Disorders Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monogenetic Disorders Testing as of 2021)
Figure 20. The Top 10 and 5 Players Market Share by Monogenetic Disorders Testing Revenue in 2021
Figure 21. North America Monogenetic Disorders Testing Revenue Market Share by Company in 2021
Figure 22. North America Monogenetic Disorders Testing Revenue Market Share by Type (2017-2028)
Figure 23. North America Monogenetic Disorders Testing Revenue Market Share by Application (2017-2028)
Figure 24. North America Monogenetic Disorders Testing Revenue Share by Country (2017-2028)
Figure 25. U.S. Monogenetic Disorders Testing Revenue (2017-2028) & (US$ Million)
Figure 26. Canada Monogenetic Disorders Testing Revenue (2017-2028) & (US$ Million)
Figure 27. Europe Monogenetic Disorders Testing Revenue Market Share by Company in 2021
Figure 28. Europe Monogenetic Disorders Testing Revenue Market Share by Type (2017-2028)
Figure 29. Europe Monogenetic Disorders Testing Revenue Market Share by Application (2017-2028)
Figure 30. Europe Monogenetic Disorders Testing Revenue Share by Country (2017-2028)
Figure 31. Germany Monogenetic Disorders Testing Revenue (2017-2028) & (US$ Million)
Figure 32. France Monogenetic Disorders Testing Revenue (2017-2028) & (US$ Million)
Figure 33. U.K. Monogenetic Disorders Testing Revenue (2017-2028) & (US$ Million)
Figure 34. Italy Monogenetic Disorders Testing Revenue (2017-2028) & (US$ Million)
Figure 35. Russia Monogenetic Disorders Testing Revenue (2017-2028) & (US$ Million)
Figure 36. Asia Pacific Monogenetic Disorders Testing Revenue Market Share by Company in 2021
Figure 37. Asia Pacific Monogenetic Disorders Testing Revenue Market Share by Type (2017-2028)
Figure 38. Asia Pacific Monogenetic Disorders Testing Revenue Market Share by Application (2017-2028)
Figure 39. Asia Pacific Monogenetic Disorders Testing Revenue Share by Region (2017-2028)
Figure 40. China Monogenetic Disorders Testing Revenue (2017-2028) & (US$ Million)
Figure 41. Japan Monogenetic Disorders Testing Revenue (2017-2028) & (US$ Million)
Figure 42. South Korea Monogenetic Disorders Testing Revenue (2017-2028) & (US$ Million)
Figure 43. India Monogenetic Disorders Testing Revenue (2017-2028) & (US$ Million)
Figure 44. Australia Monogenetic Disorders Testing Revenue (2017-2028) & (US$ Million)
Figure 45. Taiwan Monogenetic Disorders Testing Revenue (2017-2028) & (US$ Million)
Figure 46. Indonesia Monogenetic Disorders Testing Revenue (2017-2028) & (US$ Million)
Figure 47. Thailand Monogenetic Disorders Testing Revenue (2017-2028) & (US$ Million)
Figure 48. Malaysia Monogenetic Disorders Testing Revenue (2017-2028) & (US$ Million)
Figure 49. Philippines Monogenetic Disorders Testing Revenue (2017-2028) & (US$ Million)
Figure 50. Vietnam Monogenetic Disorders Testing Revenue (2017-2028) & (US$ Million)
Figure 51. Latin America Monogenetic Disorders Testing Revenue Market Share by Company in 2021
Figure 52. Latin America Monogenetic Disorders Testing Revenue Market Share by Type (2017-2028)
Figure 53. Latin America Monogenetic Disorders Testing Revenue Market Share by Application (2017-2028)
Figure 54. Latin America Monogenetic Disorders Testing Revenue Share by Country (2017-2028)
Figure 55. Mexico Monogenetic Disorders Testing Revenue (2017-2028) & (US$ Million)
Figure 56. Brazil Monogenetic Disorders Testing Revenue (2017-2028) & (US$ Million)
Figure 57. Argentina Monogenetic Disorders Testing Revenue (2017-2028) & (US$ Million)
Figure 58. Middle East and Africa Monogenetic Disorders Testing Revenue Market Share by Company in 2021
Figure 59. Middle East and Africa Monogenetic Disorders Testing Revenue Market Share by Type (2017-2028)
Figure 60. Middle East and Africa Monogenetic Disorders Testing Revenue Market Share by Application (2017-2028)
Figure 61. Middle East and Africa Monogenetic Disorders Testing Revenue Share by Country (2017-2028)
Figure 62. Turkey Monogenetic Disorders Testing Revenue (2017-2028) & (US$ Million)
Figure 63. Saudi Arabia Monogenetic Disorders Testing Revenue (2017-2028) & (US$ Million)
Figure 64. UAE Monogenetic Disorders Testing Revenue (2017-2028) & (US$ Million)
Figure 65. Celera Group Revenue Growth Rate in Monogenetic Disorders Testing Business (2017-2022)
Figure 66. Abbott Revenue Growth Rate in Monogenetic Disorders Testing Business (2017-2022)
Figure 67. Thermo Fisher Scientific Revenue Growth Rate in Monogenetic Disorders Testing Business (2017-2022)
Figure 68. ELITech Group Revenue Growth Rate in Monogenetic Disorders Testing Business (2017-2022)
Figure 69. Quest Revenue Growth Rate in Monogenetic Disorders Testing Business (2017-2022)
Figure 70. AutoGenomics Revenue Growth Rate in Monogenetic Disorders Testing Business (2017-2022)
Figure 71. PerkinElmer Revenue Growth Rate in Monogenetic Disorders Testing Business (2017-2022)
Figure 72. Roche Revenue Growth Rate in Monogenetic Disorders Testing Business (2017-2022)
Figure 73. Bio-Rad Revenue Growth Rate in Monogenetic Disorders Testing Business (2017-2022)
Figure 74. Transgenomic Revenue Growth Rate in Monogenetic Disorders Testing Business (2017-2022)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed